These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7364527)

  • 21. Application of the modified one-compartment open model in pharmacokinetic investigations.
    Bialik W
    Pharmazie; 1985 Feb; 40(2):120-1. PubMed ID: 4001147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Lombardo F; Obach RS; Shalaeva MY; Gao F
    J Med Chem; 2004 Feb; 47(5):1242-50. PubMed ID: 14971904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model to describe myocardial drug disposition in the dog.
    Kates RE; Jaillon P
    J Pharmacol Exp Ther; 1980 Jul; 214(1):31-6. PubMed ID: 7391969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The two-compartment recirculatory pharmacokinetic model--an introduction to recirculatory pharmacokinetic concepts.
    Upton RN
    Br J Anaesth; 2004 Apr; 92(4):475-84. PubMed ID: 14766714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New method that gives true least squares fit of one and two compartment open pharmacokinetic models applied to valproic acid and methadone.
    Lawyer CH; Gerber N
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):253-68. PubMed ID: 6777838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using pharmacokinetics in drug therapy III: Estimating dosage regimens and blood levels using the fraction-lost method.
    Schumacher GE
    Am J Hosp Pharm; 1978 Aug; 35(8):955-8. PubMed ID: 677145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The method of statistical moments and the integral model-independent parameters of pharmacokinetics].
    Piotrovskiĭ VK
    Farmakol Toksikol; 1986; 49(5):118-27. PubMed ID: 3533616
    [No Abstract]   [Full Text] [Related]  

  • 28. Elimination half-life of drugs: value and limitations.
    Greenblatt DJ
    Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation.
    Koehntop DE; Noormohamed SE; Fletcher CV
    Pharmacotherapy; 1994; 14(5):592-9. PubMed ID: 7997393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial slope technique for estimation of the apparent volume of distribution during constant-rate intravenous infusion.
    Cocchetto JF; Cocchetto DM; Bjornsson TD; Bergan T
    J Pharm Sci; 1984 Jan; 73(1):58-62. PubMed ID: 6694084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mathematical analysis concerning the dosage regimen of intravenous infusion of two-compartment model drugs (author's transl)].
    Zhu JB
    Yao Xue Xue Bao; 1980 Dec; 15(12):741-9. PubMed ID: 7257801
    [No Abstract]   [Full Text] [Related]  

  • 33. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetic models].
    Dahl S
    Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
    [No Abstract]   [Full Text] [Related]  

  • 35. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic prediction of tissue residues.
    Dittert LW
    J Toxicol Environ Health; 1977 Mar; 2(4):735-56. PubMed ID: 857040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population one-compartment pharmacokinetic analysis with missing dosage data.
    Soy D; Beal SL; Sheiner LB
    Clin Pharmacol Ther; 2004 Nov; 76(5):441-51. PubMed ID: 15536459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biotransformation of drugs during aging.
    Gillette JR
    Fed Proc; 1979 Apr; 38(5):1900-9. PubMed ID: 428574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.